ASCO
Navigation Links
ASCO at Biology News
No data found
Search ASCO biology news at Google
Search ASCO biology news at Yahoo
Search ASCO biology news at Msn
ASCO at Biology Products
DNAscope AT from Biomedical Photometrics Inc.
Description:'A New Concept in Microarrays: Biomedical Photometrics Inc. (Waterloo, Ontario, Canada) and CLONDIAG chip technologies GmbH (Jena, Germany) have collaborated to develop a fluorescence reader for the new CLONDIAG ArrayTube System. The DNAscope AT is based on BPIs patented MACROscope technology. The new DNAscope AT automatically reads up to six ArrayTubes in sequence using a confocal laser scannin...Company:Biomedical Photometrics Inc.
Open Frame DNAscope from Biomedical Photometrics Inc.
Description:The Open Frame DNAscope is an integrated confocal laser scanner designed to be flexible, customizable, and readily integrated into your specific application. GeneFocus can recommend a standard configuration, or we can tailor the system to your specifications. The Open Frame DNAscopes patented optical scanning design has been modularized and built onto an optical board to scan virtually any size...Company:Biomedical Photometrics Inc.
FP-6500/6600 research-grade fluorescence spectrometers from JASCO
Description:The FP-6500 is the research-grade spectrofluorometer with a minimum 1 nm resolution and a highest sensitivity S/N ratio 200 or greater for the Raman band of water. The FP-6500 is especially designed to keep in mind in order to meet requirements in biochemistry as kinetics, stopped-flow, titration, or anisotropic measurements. The FP-6500 is designed to keep GLP/GMP compliance in mind. Bui...Company:JASCO
The DNAscope LM from Biomedical Photometrics Inc.
Description:'The DNAscope LM is a high quality microarray scanner based on patented confocal laser imaging technology for optimal background rejection and spatial resolution. The DNAscope LM is unique because it is the only low cost microarray scanner that is upgradeable to a total of 3 laser excitation sources. <...Company:Biomedical Photometrics Inc.
HV-2080-01 Column Switching Valve from JASCO
Description:Contact us for more information...Company:JASCO
ASCO at Biology Technology
Nanotechnology minimizes UW's beloved mascot
Last month a team of UW-Madison chemists led by <a href="http://hamers.chem.wis...Tascon Group launches online business valuation tool
The Business Analyst is being offered as a licensed software application, and is available at The program is based on a bus...ASCO at Biology Dictionary
auricle. A small earlike projection from the <a href="/
?q=/
Biology-Dictionary/
b...
ASCO at Medicine News
Intravenous Vitamin C (Ascorbate) for Cancer Treatment
Research has found that Intravenous Vitamin C administration in the form of Ascorbate was tested on nine cancer cell lines and four normal cell lines. The vitamin C did not have any effect or toxicity in normal cell // lines but Killed 50% of cancer cells in the tissue culture animal cell line and almost 100% sensitive on lymphoma cell lines. Dr. Mark Levine and colleagues from Instit...Astrazeneca's Investigational Cancer Therapies Revealed at ASCO
CHICAGO, AstraZeneca today announced details of two new investigational cancer therapies at the American Society of Clinical Oncology (ASCO) meeting. AZD2281 (KU-0059436) is a small molecule inhibitor of Poly-ADP Ribose Polymerase (PARP). PARP is an enzyme involved in Base Excision Repair which is a key pathway in the repair of DNA single-stranded breaks. Inhibiting this DNA repair...ASCO at Medicine Products
Description:The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm and 6 mm....
Company:VascomedDescription:The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm and 6 mm....
Company:VascomedDescription:The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm and 6 mm....
Company:VascomedDescription:The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm and 6 mm....
Company:VascomedDescription:VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Company:Vascomed
Company:VascomedDescription:The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm and 6 mm....
Company:VascomedDescription:The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm and 6 mm....
Company:VascomedDescription:The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm and 6 mm....
Company:VascomedDescription:VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Company:Vascomed
ASCO at Medicine Technology
Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
Safety, Efficacy and Markers Demonstrated in Combination Trial ROCKVILLE, Md., June 06, 2007 /PRNewswire-FirstCall/ --EntreMed, Inc. , a clinical-stage pharmaceutical company developingtherapeutics primarily for the treatment of cancer and inflammatorydiseases, announced the presentation of interim data from the Phase1b study with Panzem(R) NCD (2ME2 or 2-methoxyestradiol) incombination w...Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
NEW YORK--(BUSINESS WIRE)--Jun 5, 2007 - ERBITUX (cetuximab), thefirst approved IgG1 monoclonal antibody targeting the epidermalgrowth factor receptor (EGFR) developed and commercialized byImClone Systems Incorporated, was the focus of nine oral and 46poster presentations at the recently concluded 43rd Annual Meetingof the American Society of Clinical Oncology (ASCO). This year's ASCO ERB...CHICAGO, DARMSTADT, Germany, June 5, 2007 – Thisyear’s American Society of Clinical Oncology (ASCO) meetingin Chicago sees a wealth of promising new data presented regardingMerck KGaA’s targeted cancer therapy Erbitux®(cetuximab), further demonstrating the consistent efficacy andversatility of this agent in both first-line and subsequenttreatment of metastatic color...
Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
NEW YORK--(BUSINESS WIRE)--Jun 5, 2007 - First-in-human results forIMC-A12, a monoclonal antibody developed by ImClone SystemsIncorporated (NASDAQ: IMCL) and targeted to IGF-1R (insulin-likegrowth factor type 1 receptor), were presented at the annualmeeting of the American Society of Clinical Oncology in Chicago.The IGF-IR is expressed on the cell surface of must human cancersand transmits...Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
Data From the Companies' Novel Heat Shock Protein 90 InhibitorReveal Further Evidence of Safety, Tolerability, and BiologicalActivity CAMBRIDGE, Mass. and GAITHERSBURG, Md., June 5, 2007 (PRIMENEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) andMedImmune, Inc. (Nasdaq:MEDI) today announced updated interimresults from a Phase I clinical trial of the companies' heat shockpr...ASCO at Medicine Dictionary
Tell your health care professional if you have ever had any unusual or allergic reaction to <A href="http:/
/
www.mayoc...
Other TagsbioengineerabsorbDigDigDigDigDigDigDigpillpillpillpillpillOther Contentshypoglycemiahypoglycemiahypoglycemiahypogonadismhypogonadismhypokalemiahypoplastichypospadiashypospadiashypoparathyroidismhypopituitarismhypotensionhypotension
(Date:5/16/2008)... Pledge to Save Vital Services for Frail Seniors ...y 16 /PRNewswire-USNewswire/ -- Thousands of,homec...Arnold,Schwarzenegger,s proposed cuts to hours of ...e of California,s most vulnerable workers and the,...d to save these vital,services for seniors and peo...
(Date:5/16/2008)...,What this country needs is more unemployed politi...RNewswire-FirstCall/ -- Although nearly all,voters...tant issues" list,a looming federal budgetary cru...y any of the current presidential candidates is li...Senate Majority Leader Bill Frist., Jousting with...
(Date:5/16/2008)...Four and five year-old Chinese students learn the ...ke of the Sichuan earthquake, NANJING, China, May...ating Sichuan earthquake, even the youngest member...ation and relief efforts. All around the,country, ...ng campaigns.,Led by the school,s principal, Ms. Z...
(Date:5/16/2008)... SAN DIEGO, May 16 /PRNewswire-FirstCall/ -- Cry...y focused on the treatment of cardiac,arrhythmias,...holders of,CryoCor common stock filed a complaint ...County of San Diego, naming as defendants each mem...and Boston Scientific Corporation.,The complaint i...
Breaking Medicine News(10 mins):Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4[0] Homecare Workers Outraged by Proposed Cuts, Wage Reductions[0] Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care[0] Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake[0] CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger
(Date:5/15/2008)...separate groups within Africa for as much as half ...matician. Climate change, reduction in populations...ed the separation. , Dr. Saharon Rosset, from t...versity, worked with team leader Doron Behar from ...Their goal was to study obscure population pattern...
(Date:5/15/2008)...ing through a room full of people. Jumping out of ... these seemingly simple actions require us to perc... Professor of Cognitive Science at Rensselaer Poly...e something moreour ability to foresee the future....nd to translate the light that hits our retina int...
(Date:5/15/2008)...celebrated brother will each receive honorary doct...st year each brother was named in the Queens Honou...of Nottingham Research Professor in Chemistry, Mar...med playwright and director Stephen Poliakoff CBE,...kable contribution to British science and culture....
(Date:5/14/2008)...kes with things like trout and salmon would be goo...the water, so it would be natural to assume that m...rt published in the April journal of Ecology by th...tion of species such as exotic salmon and trout to...rating that fishery management actions can sometim...
Breaking Biology News(10 mins):Long lost sisters 2Crystal (eye) ball: Study says visual system equipped with 'future seeing powers' 2Crystal (eye) ball: Study says visual system equipped with 'future seeing powers' 3Boffinry and Baftas: Brothers' double doctorates 2Restoring fish populations leads to tough choice for Great Lakes Gulls 2Presidents Veto of Childrens Health Bill Marks First Round in National Fight About Health Care 2820 1Streamline Health Announces Executive Management Changes 2817 1Streamline Health Announces Executive Management Changes 2817 2Streamline Health Announces Executive Management Changes 2817 3Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe 1031 1Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe 1031 2Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe 1031 3The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation 1028 1The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation 1028 2| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |